Organovo to present data of FXR314 in Phase 2 MASH study
Organovo (ONVO) announces that its lead clinical stage drug, FXR314 will be featured in an oral presentation at The Liver Meeting, sponsored by ...
Zacks Small Cap Research on MSN3d
ONVO Releases Encouraging Quarterly Results
ONVO READ THE FULL ONVO RESEARCH REPORT Organovo Holdings (NASDAQ:ONVO) is a biotechnology company that is both a developer of 3D tissue technology that has the potential to change the way treatments ...
Yahoo Finance6d
Organovo: Fiscal Q2 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Organovo Holdings Inc. (ONVO) on Friday reported a loss of $2.5 million in its fiscal second quarter. The San Diego-based company said it had a loss of 14 cents per ...
SFGate7d
Organovo: Fiscal Q2 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — Organovo Holdings Inc. (ONVO) on Friday reported a loss of $2.5 million in its fiscal second quarter. The San Diego-based company said it had a loss of 14 ...